Form 4: Guided Therapeutics Director Acquires Stock Options

Sentiment:

SEC Filing Form 4


Richard P. Blumberg, a director and 10% owner of Guided Therapeutics Inc., acquired stock options on July 9, 2024.

Summary

  • Richard P. Blumberg, a director and 10% owner of Guided Therapeutics Inc. (GTHP), filed a Form 4 indicating changes in beneficial ownership.
  • On July 9, 2024, Blumberg acquired stock options for 100,000 shares at an exercise price of $0.12.
  • One-fourth of the shares vested immediately on July 9, 2024, with the remaining shares vesting monthly starting October 9, 2024, until fully vested on July 8, 2027, contingent upon continued service.
  • Following the transaction, Blumberg directly owns 200,000 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. It doesn't inherently indicate positive or negative performance for the company.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment of interests between management and shareholders.

Stakeholder Impact

  • The acquisition of stock options by a director could be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates

DateDescription
07/09/2024Date of the stock option acquisition and initial vesting.
10/09/2024Start date for monthly vesting of remaining shares.
07/08/2027Date when the stock options are fully vested.
09/04/2024Date of signature on the Form 4 filing.

Keywords

Form 4, beneficial ownership, stock options, Guided Therapeutics, GTHP, Richard Blumberg, director, insider trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.